CINCOR PHARMA INC's ticker is and the CUSIP is 17240Y109. A total of 54 filers reported holding CINCOR PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,337,646 | $76,082,000 | 16.62% |
| venBio Partners LLC | 1,980,706 | $34,742,000 | 7.70% |
| Sofinnova Investments, Inc. | 5,573,949 | $97,767,000 | 7.42% |
| Sands Capital Ventures, LLC | 950,000 | $16,663,000 | 3.48% |
| Omega Fund Management, LLC | 966,176 | $16,947,000 | 3.47% |
| BVF INC/IL | 1,735,293 | $30,437,000 | 1.22% |
| Perceptive Advisors | 2,319,117 | $40,677,000 | 0.82% |
| GENERAL ATLANTIC, L.P. | 4,126,470 | $72,378,000 | 0.66% |
| RTW INVESTMENTS, LP | 1,389,705 | $24,375,000 | 0.50% |
| Rock Springs Capital Management LP | 1,031,159 | $18,087,000 | 0.46% |